CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
24.33
1.93%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.22
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Zai Lab Ltd ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 23.87
Open* 24.84
1-Year Change* -41.98%
Day's Range* 24.28 - 24.84
52 wk Range 20.98-53.95
Average Volume (10 days) 633.99K
Average Volume (3 months) 10.49M
Market Cap 2.70B
P/E Ratio -100.00K
Shares Outstanding 968.57M
Revenue 251.80M
EPS -4.09
Dividend (Yield %) N/A
Beta 1.10
Next Earnings Date Nov 7, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 22, 2023 24.33 -0.35 -1.42% 24.68 24.84 24.18
Sep 21, 2023 23.87 -0.44 -1.81% 24.31 24.40 23.68
Sep 20, 2023 25.27 0.41 1.65% 24.86 25.73 24.86
Sep 19, 2023 25.24 -0.06 -0.24% 25.30 25.34 24.04
Sep 18, 2023 25.70 -0.28 -1.08% 25.98 27.71 25.56
Sep 15, 2023 25.69 0.42 1.66% 25.27 25.92 24.96
Sep 14, 2023 25.51 0.30 1.19% 25.21 26.42 25.21
Sep 13, 2023 24.99 -1.49 -5.63% 26.48 26.48 24.92
Sep 12, 2023 26.42 1.07 4.22% 25.35 26.43 25.35
Sep 11, 2023 26.38 -0.44 -1.64% 26.82 27.41 25.99
Sep 8, 2023 26.32 -0.51 -1.90% 26.83 26.98 25.79
Sep 7, 2023 27.24 0.29 1.08% 26.95 27.84 26.26
Sep 6, 2023 28.12 0.25 0.90% 27.87 28.17 27.28
Sep 5, 2023 28.56 -0.06 -0.21% 28.62 28.77 27.93
Sep 1, 2023 26.00 0.35 1.36% 25.65 26.38 25.49
Aug 31, 2023 25.36 -0.63 -2.42% 25.99 26.69 25.23
Aug 30, 2023 26.41 2.31 9.59% 24.10 26.71 24.10
Aug 29, 2023 23.74 0.96 4.21% 22.78 23.87 22.39
Aug 28, 2023 22.72 -0.63 -2.70% 23.35 23.63 22.39
Aug 25, 2023 23.94 -0.14 -0.58% 24.08 24.08 23.35

Zai Lab Limited Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 215.04 144.312 48.958 12.985 0.12945
Total Operating Expense 619.397 844.376 350.759 216.181 141.898
Selling/General/Admin. Expenses, Total 258.971 218.831 111.312 70.211 21.5759
Research & Development 286.408 573.306 222.711 142.221 120.278
Operating Income -404.357 -700.064 -301.801 -203.196 -141.768
Interest Income (Expense), Net Non-Operating -41.821 2.19 4.939 7.939 3.22096
Other, Net 3.113 -5.54 29.076 0.938 0.05878
Net Income Before Taxes -443.065 -703.414 -267.786 -194.319 -138.488
Net Income After Taxes -443.065 -703.414 -267.786 -194.319 -138.488
Net Income Before Extra. Items -443.286 -704.471 -268.905 -195.071 -139.075
Net Income -443.286 -704.471 -268.905 -195.071 -139.075
Income Available to Common Excl. Extra. Items -443.286 -704.471 -268.905 -195.071 -139.075
Income Available to Common Incl. Extra. Items -443.286 -704.471 -268.905 -195.071 -139.075
Dilution Adjustment
Diluted Net Income -443.286 -704.471 -268.905 -195.071 -139.075
Diluted Weighted Average Shares 958.067 929.921 77.6677 64.3695 52.6098
Diluted EPS Excluding Extraordinary Items -0.46269 -0.75756 -3.46225 -3.03049 -2.64352
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -0.46269 -0.75756 -3.46225 -3.03049 -2.64352
Equity In Affiliates -0.221 -1.057 -1.119 -0.752 -0.58655
Revenue 215.04 144.312 48.958 12.985 0.12945
Cost of Revenue, Total 74.018 52.239 16.736 3.749 0.04359
Gross Profit 141.022 92.073 32.222 9.236 0.08586
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 68.864 62.797 62.601 57.54 48.176
Revenue 68.864 62.797 62.601 57.54 48.176
Cost of Revenue, Total 23.763 21.337 20.924 20.044 17.407
Gross Profit 45.101 41.46 41.677 37.496 30.769
Total Operating Expense 158.365 132.319 159.894 186.123 146.892
Selling/General/Admin. Expenses, Total 67.92 62.51 72.024 66.555 63.401
Research & Development 76.682 48.472 66.946 99.524 66.084
Operating Income -89.501 -69.522 -97.293 -128.583 -98.716
Interest Income (Expense), Net Non-Operating -29.989 19.144 -47.056 3.872 1.175
Other, Net -1.405 1.234 82.58 -36.479 -40.392
Net Income Before Taxes -120.895 -49.144 -61.769 -161.19 -137.933
Net Income After Taxes -120.895 -49.144 -61.769 -161.19 -137.933
Equity In Affiliates 0 0 0 0 0
Net Income Before Extra. Items -120.895 -49.144 -61.769 -161.19 -137.933
Net Income -120.895 -49.144 -61.769 -161.19 -137.933
Income Available to Common Excl. Extra. Items -120.895 -49.144 -61.769 -161.19 -137.933
Income Available to Common Incl. Extra. Items -120.895 -49.144 -61.769 -161.19 -137.933
Diluted Net Income -120.895 -49.144 -61.769 -161.19 -137.933
Diluted Weighted Average Shares 964.817 961.445 959.949 959.086 957.685
Diluted EPS Excluding Extraordinary Items -0.1253 -0.05111 -0.06435 -0.16807 -0.14403
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.13567 -0.05111 -0.06435 -0.16807 -0.14403
Unusual Expense (Income) -10
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1124.34 1500.88 1216.04 292.464 269.144
Cash and Short Term Investments 1008.47 1409.1 1186.79 275.932 263.302
Cash 1007.42 663.472 441.283 75.111 36.778
Cash & Equivalents 1.047 300.628 0.833 0.821 26.1736
Prepaid Expenses 35.674 18.021 10.935 6.736 5.74926
Total Assets 1220.14 1609.96 1297.64 355.153 301.987
Property/Plant/Equipment, Total - Net 77.375 57.291 46.863 36.424 20.4945
Property/Plant/Equipment, Total - Gross 99.439 73.716 57.115 41.885 22.7024
Accumulated Depreciation, Total -22.064 -16.425 -10.252 -5.461 -2.20792
Intangibles, Net 8.403 9.659 9.44 8.803 0.32157
Long Term Investments 6.431 15.605 1.279 2.398 3.14986
Note Receivable - Long Term 0 23.858 22.141 13.737 8.04426
Other Long Term Assets, Total 3.595 2.662 1.879 1.327 0.83259
Total Current Liabilities 139.842 192.901 98.043 46.635 48.8415
Accounts Payable 65.974 126.163 62.641 22.66 37.432
Accrued Expenses 38.739 31.612 18.9 13.941 3.69917
Notes Payable/Short Term Debt 0 0 0 6.45 3.64262
Other Current Liabilities, Total 35.129 35.126 16.502 3.584 4.06767
Total Liabilities 174.545 230 128.293 60.493 50.9054
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 34.703 37.099 30.25 13.858 2.06394
Total Equity 1045.59 1379.96 1169.34 294.66 251.082
Redeemable Preferred Stock
Common Stock 0.006 0.006 0.005 0.004 0.00348
Additional Paid-In Capital 2893.12 2825.95 1897.47 734.734 498.043
Retained Earnings (Accumulated Deficit) -1861.36 -1418.07 -713.603 -444.698 -249.627
Other Equity, Total 25.685 -23.645 -14.524 4.62 2.66173
Total Liabilities & Shareholders’ Equity 1220.14 1609.96 1297.64 355.153 301.987
Total Common Shares Outstanding 960.22 95.4981 87.811 68.2373 49.9126
Short Term Investments 0 445 744.676 200 200.35
Total Receivables, Net 48.571 54.809 5.165 3.791 0.08971
Accounts Receivable - Trade, Net 39.963 47.474 5.165 3.791 0.08971
Total Inventory 31.621 18.951 13.144 6.005 0.00382
Treasury Stock - Common -11.856 -4.279
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 1072.3 1124.34 1209.83 1335.65 1393.25
Cash and Short Term Investments 930.394 1008.47 1119.48 1256.09 1312.23
Cash 878.786 1007.42 818.407 381.225 547.259
Cash & Equivalents 1.058 1.047 301.069 299.595 299.698
Short Term Investments 50.55 0 0 575.274 465.274
Total Receivables, Net 60.727 48.571 39.067 38.241 44.242
Accounts Receivable - Trade, Net 43.346 39.963 27.736 27.054 33.394
Total Inventory 38.405 31.621 29.131 23.339 20.288
Prepaid Expenses 42.772 35.674 22.157 17.973 16.49
Total Assets 1170.07 1220.14 1298.51 1418.78 1500.92
Property/Plant/Equipment, Total - Net 78.457 77.375 70.797 65.015 62.213
Property/Plant/Equipment, Total - Gross 102.936 99.439 91.11 84.148 80.461
Accumulated Depreciation, Total -24.479 -22.064 -20.313 -19.133 -18.248
Intangibles, Net 8.399 8.403 8.364 8.959 9.519
Long Term Investments 6.872 6.431 3.316 2.827 8.444
Note Receivable - Long Term 0 0.006 0.037 20.766
Other Long Term Assets, Total 4.048 3.595 6.2 6.292 6.722
Total Current Liabilities 124.56 139.842 155.548 168.877 154.912
Accounts Payable 66.361 65.974 90.112 108.443 98.161
Accrued Expenses 18.79 38.739 32.188 25.8 23.113
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 39.409 35.129 33.248 34.634 33.638
Total Liabilities 168.832 174.545 192.645 206.612 192.907
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 44.272 34.703 37.097 37.735 37.995
Total Equity 1001.24 1045.59 1105.87 1212.17 1308.01
Common Stock 0.006 0.006 0.006 0.006 0.006
Additional Paid-In Capital 2911.45 2893.12 2877.36 2857.2 2838.66
Retained Earnings (Accumulated Deficit) -1910.5 -1861.36 -1799.59 -1638.4 -1500.47
Other Equity, Total 17.272 25.685 39.549 4.487 -25.838
Total Liabilities & Shareholders’ Equity 1170.07 1220.14 1298.51 1418.78 1500.92
Total Common Shares Outstanding 963.689 960.22 959.725 958.495 956.637
Treasury Stock - Common -16.986 -11.856 -11.456 -11.129 -4.347
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -443.286 -704.471 -268.905 -195.071 -139.075
Cash From Operating Activities -367.642 -549.231 -216.055 -191.011 -97.538
Cash From Operating Activities 8.227 6.487 4.64 3.766 1.63438
Amortization 0.0154
Non-Cash Items 133.187 124.275 29.935 23.577 12.5049
Changes in Working Capital -65.77 24.478 18.275 -23.283 27.3822
Cash From Investing Activities 420.016 249.957 -554.83 -14.892 -212.554
Capital Expenditures -24.984 -18.948 -10.669 -15.242 -10.1178
Other Investing Cash Flow Items, Total 445 268.905 -544.161 0.35 -202.436
Cash From Financing Activities -1.73 820.202 1132.44 219.302 144.147
Issuance (Retirement) of Stock, Net 5.87 824.455 1138.97 216.401 140.504
Foreign Exchange Effects -6.274 1.116 4.862 0.091 -0.76342
Net Change in Cash 44.37 522.044 366.417 13.49 -166.709
Cash Interest Paid 0 0 0.189 0.288 0.0358
Issuance (Retirement) of Debt, Net 0 0 -6.527 2.901 3.64262
Financing Cash Flow Items -7.6 -4.253
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -49.144 -443.286 -381.517 -220.327 -82.394
Cash From Operating Activities -69.287 -367.642 -258.35 -132.027 -87.127
Cash From Operating Activities 2.657 8.227 6.1 3.874 2.013
Non-Cash Items 9.255 133.187 134.847 41.836 20.867
Cash Interest Paid 0
Changes in Working Capital -32.055 -65.77 -17.78 42.59 -27.613
Cash From Investing Activities -53.954 420.016 424.389 -143.869 -30.144
Capital Expenditures -3.516 -24.984 -20.611 -13.595 -9.895
Other Investing Cash Flow Items, Total -50.438 445 445 -130.274 -20.249
Cash From Financing Activities -3.886 -1.73 -1.531 -2.24 0.258
Issuance (Retirement) of Stock, Net 1.197 5.87 5.64 4.619 0.297
Issuance (Retirement) of Debt, Net 0
Foreign Exchange Effects -1.299 -6.274 -9.132 -5.144 -0.13
Net Change in Cash -128.426 44.37 155.376 -283.28 -117.143
Financing Cash Flow Items -5.083 -7.6 -7.171 -6.859 -0.039
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Capital World Investors Investment Advisor 5.2849 5223568 557699 2023-06-30 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 3.7301 3686754 1815712 2023-06-30 LOW
Invesco Advisers, Inc. Investment Advisor 3.5809 3539301 -1161245 2023-06-30 LOW
Viking Global Investors LP Investment Advisor/Hedge Fund 2.6603 2629445 298200 2023-06-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.6526 2621802 215729 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.0997 2075352 760307 2023-06-30 LOW
Segantii Capital Management Limited Hedge Fund 1.8166 1795479 -482796 2023-06-30 HIGH
Baron Capital Management, Inc. Investment Advisor/Hedge Fund 1.5298 1512061 86847 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.5134 1495869 -1175601 2023-06-30 LOW
Genesis Investment Management, LLP Investment Advisor/Hedge Fund 1.3681 1352222 -217542 2023-06-30 LOW
Qiming Venture Partners Venture Capital 1.2829 1268000 -6654932 2022-12-31 LOW
Rock Springs Capital Management LP Hedge Fund 1.2368 1222423 162723 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0804 1067883 433972 2022-12-31 LOW
Du (Samantha Ying) Individual Investor 1.0145 1002701 1002701 2023-04-17
Capital International Investors Investment Advisor 0.9782 966853 250155 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.9456 934602 161982 2023-06-30 LOW
Paradigm BioCapital Advisors LP Investment Advisor 0.8755 865297 84739 2023-06-30 LOW
ClearBridge Investments, LLC Investment Advisor/Hedge Fund 0.8208 811314 15101 2023-06-30 LOW
SC China Holding Ltd Investment Advisor 0.7028 694634 0 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.6776 669739 -616150 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Zai Lab Limited Company profile

Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China. Its drug candidates include ZL-2306, a poly ADP ribose polymerase 1/2 inhibitor, which is in Phase III clinical trial for the treatment of ovarian, lung, and breast cancers; ZL-2401, an antibiotic that is in Phase III clinical trial to treat ABSSSI, CABP, and UTI; FPA144, a humanized monoclonal antibody, which is in Phase I/III clinical trial to treat gastric and gastroesophageal cancer; ETX2514, a novel ß-lactamase inhibitor that is in Phase II cUTI trial for the treatment of acinetobacter baumannii; and ZL-2301, which is in Phase III clinical trial to treat HCC. The company's drug candidates also comprise ZL-3101, a novel steroid-sparing topical product that is in Phase II clinical trial for the treatment of eczema and psoriasis; and ZL-2302 to treat non-small cell lung cancer. The company, through its subsidiary, Zai Lab (Shanghai) Co. Ltd., has a collaboration agreement with the NovoCure Limited to perform clinical studies, sell, and import tumor treating field products in the field of oncology. Zai Lab Limited was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Industry: Biopharmaceuticals

4560 Jinke Road
Bldg. 1, 4/F
SHANGHAI
SHANGHAI 201210
CN

Income Statement

  • Annual
  • Quarterly

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

BTC/USD

26,619.30 Price
+0.150% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

XRP/USD

0.51 Price
-0.620% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Oil - Crude

90.14 Price
+0.770% 1D Chg, %
Long position overnight fee 0.0415%
Short position overnight fee -0.0634%
Overnight fee time 21:00 (UTC)
Spread 0.030

ETH/USD

1,596.02 Price
+0.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading